BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:93aa2382d56150e062dce4c14a99759c
DTSTAMP:20260716T093315Z
SUMMARY:Building successful biotechnology companies to treat disease
DESCRIPTION:\nWhat is the event about?\nProfessor Lodish will share insight
 s from his academic career and his experience co-founding biotechnology co
 mpanies Genzymeand Millennium Pharmaceuticals\, including perspectives o
 n mentorship\, ethics\, and the relationship between research excellence a
 nd commercialising technology. The lecture will be followed by Q&A and net
 working over lunch\, with a panel discussion after lunch.\n \n\nWho are e
 vent speakers?\n\nProf Havey Lodish\, Professor of Biology and Biological 
 Engineering\, Whitehead Institute for Biomedical Research\, MIT\nDr Mike R
 omanos\, Associate Dean for Enterprise\, Faculty of Medicine\, Imperial Co
 llege London\nDr Barbara Domayne-Hayman\, KQ Labs Chair & Entrepreneur in 
 Residence\, Francis Crick Institute\nDr Maria Leiloglou\, CEO\, EnAcuity L
 td\nDr Brian Sheehan\, Executive Director\, Institute for Deep Tech Entrep
 reneurship\, Imperial College London\nProf Ed Tate\, GSK Chair in Chemical
  Biology\, Department of Chemistry\, Imperial College London\, Co-founder 
 and Chairman of the Scientific Advisory Board\, MyricxBio Ltd\,\n\n\n \nW
 hat can you expect to take away from our event?\n\nThe event will explore 
 how fundamental scientific discovery can be translated into real‑world b
 enefit and the role universities play in supporting that journey with inte
 grity\, responsibility\, and long‑term vision.\nProfessor Harvey Lodish\
 , Professor of Biology and Biological Engineering at MIT\, will give this 
 special lecture and discussion during his visit to the UK\, where he under
 took postdoctoral research at the MRC Laboratory of Molecular Biology\, Ca
 mbridge.\nThe lecture will be followed by a question-and-answer session\nN
 etworking over lunch\nExpert panel discussion after lunch.\n\n \n\nWho sh
 ould attend?\n\n\n\n\n\n\nThis event is open to members of Imperial\, the 
 Crick Institute and MRC Laboratory of Medical Sciences.\n\n\n\n \nWhat is
  the agenda?\n\nFull agenda available on Eventbrite\n\n\n \nWhat else do 
 I need to know?\n\nPlease complete your registration in full to confirm yo
 ur job title\, company\, and dietary and accessibility requirements.\nThis
  is a ticketed event with limited space. We reserve the right to cancel yo
 ur ticket.\nThere will be photography and filming at this event.\nFor venu
 e accessibility information\, please contact Anne Roques\, a.roques@imperi
 al.ac.uk\nAll guests registering for this event will be expected to adhere
  to Imperial’s Institutional Events code of conduct.\nPlease return all 
 digital/print lanyards\, or a fine may be incurred.\nImperial College Lond
 on – Enterprise Division Privacy Notice\n\n\n
URL:https://www.imperial.ac.uk/events/210766/building-successful-biotechnol
 ogy-companies-to-treat-disease/
DTSTART;TZID=Europe/London:20260728T110000
DTEND;TZID=Europe/London:20260728T140000
LOCATION:-\, Sir Michael Uren Hub\, White City Campus\, Imperial College Lo
 ndon\, London\, W12 0BZ\, United Kingdom
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
DTSTART:20260728T110000
TZNAME:BST
TZOFFSETTO:+0100
TZOFFSETFROM:+0100
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR